Roche acquiring PathAI in billion-dollar deal
Swiss healthcare giant Roche has entered into a definitive merger agreement to acquire the digital pathology specialist PathAI in a transaction valued at up to $1.05 billion. The deal involves a $750 million upfront cash payment and up to $300 million in performance and regulatory milestones. Expected to close in the second half of 2026, the acquisition will fold the…